Amarogentin Suppresses Cell Proliferation and EMT Process Through Inducing Ferroptosis in Colorectal Cancer

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Date 2025 Jan 30

PMID 39885392

Authors

Chao Wang

Zihao You

Guoqing Zhou

Juanjuan Dong

Sihao Tong

Guoping Sun

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) is one common tumor with the high death rate, and badly affects the normal lives of CRC patients. Amarogentin (AG) has been found to exhibit regulatory roles and join into the progression of multiple diseases. However, the regulatory impacts and associated molecular mechanisms of AG in CRC progression keep unclear.

Methods And Results: In this study, it was demonstrated that AG weakened CRC cell viability in a concentration- and time-dependent manner. In addition, AG accelerated cell apoptosis by triggering ferroptosis. The cell invasion and EMT process were restrained after AG treatment, but these impacts were reversed after Fer-1 addition. Moreover, it was uncovered that AG retarded Nrf2/HO-1/GPX4 activation. Additionally, AG modulated PTC cell viability and stimulated ferroptosis. At last, it was illustrated that AG suppressed tumor growth in vivo.

Conclusion: In conclusion, it was disclosed that AG suppressed cell proliferation and EMT process through inducing ferroptosis in CRC, and retarded Nrf2/HO-1/GPX4 activation. This discovery suggested that AG may be one effective drug for ameliorating CRC progression.

References

Li Y, Liu J, Ma X, Bai X . Maresin-1 inhibits high glucose induced ferroptosis in ARPE-19 cells by activating the Nrf2/HO-1/GPX4 pathway. BMC Ophthalmol. 2023; 23(1):368. PMC: 10481498. DOI: 10.1186/s12886-023-03115-9. View

Li J, Dai W, Mo W, Xu W, Li Y, Guo C . Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation. J Clin Transl Hepatol. 2023; 11(6):1341-1354. PMC: 10500289. DOI: 10.14218/JCTH.2023.00133. View

Huang L, Wang J, Yu J, Bian M, Xiang X, Han G . Picein alleviates oxidative stress and promotes bone regeneration in osteoporotic bone defect by inhibiting ferroptosis via Nrf2/HO-1/GPX4 pathway. Environ Toxicol. 2024; 39(7):4066-4085. DOI: 10.1002/tox.24239. View

Jia F, Ji R, Qiao G, Sun Z, Chen X, Zhang Z . Amarogentin inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia via AMPK activation. Biochim Biophys Acta Mol Basis Dis. 2023; 1869(5):166667. DOI: 10.1016/j.bbadis.2023.166667. View

Song B, Zhou W . Amarogentin has protective effects against sepsis-induced brain injury via modulating the AMPK/SIRT1/NF-κB pathway. Brain Res Bull. 2022; 189:44-56. DOI: 10.1016/j.brainresbull.2022.08.018. View

Forcina G, Dixon S . GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis. Proteomics. 2019; 19(18):e1800311. DOI: 10.1002/pmic.201800311. View

Patel K, Kumar V, Verma A, Rahman M, Patel D . Amarogentin as Topical Anticancer and Anti-Infective Potential: Scope of Lipid Based Vesicular in its Effective Delivery. Recent Pat Antiinfect Drug Discov. 2018; 14(1):7-15. DOI: 10.2174/1574891X13666180913154355. View

Yin S, Xi R, Wu A, Wang S, Li Y, Wang C . Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med. 2020; 12(549). DOI: 10.1126/scitranslmed.aaz1723. View

Song L, Zhu S, Liu C, Zhang Q, Liang X . Baicalin triggers apoptosis, inhibits migration, and enhances anti-tumor immunity in colorectal cancer via TLR4/NF-κB signaling pathway. J Food Biochem. 2021; 46(3):e13703. DOI: 10.1111/jfbc.13703. View

10.

Wang G, Wang J, Zhi-Min Z, Xu X, Shi F, Fu X . Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer. Sci Prog. 2023; 106(1):368504221147173. PMC: 10450309. DOI: 10.1177/00368504221147173. View

11.

Yang W, Wang Y, Zhang C, Huang Y, Yu J, Shi L . Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation. Front Pharmacol. 2022; 13:865689. PMC: 9013935. DOI: 10.3389/fphar.2022.865689. View

12.

Dodson M, Castro-Portuguez R, Zhang D . NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019; 23:101107. PMC: 6859567. DOI: 10.1016/j.redox.2019.101107. View

13.

Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X . Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death Dis. 2021; 12(11):1079. PMC: 8590697. DOI: 10.1038/s41419-021-04367-3. View

14.

Cui W, Guo M, Liu D, Xiao P, Yang C, Huang H . Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nat Cell Biol. 2024; 26(1):124-137. DOI: 10.1038/s41556-023-01314-6. View

15.

Biller L, Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021; 325(7):669-685. DOI: 10.1001/jama.2021.0106. View

16.

Yang R, Gao W, Wang Z, Jian H, Peng L, Yu X . Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis. Phytomedicine. 2023; 122:155135. DOI: 10.1016/j.phymed.2023.155135. View

17.

Gao W, Huang Z, Duan J, Nice E, Lin J, Huang C . Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021; 15(12):3527-3544. PMC: 8637554. DOI: 10.1002/1878-0261.13079. View

18.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

19.

Tan Z, Wang W, Peng J, Zhou Z, Pan J, Peng A . Impact of Amarogentin on Gastric Carcinoma Cell Multiplication, Apoptosis and Migration via circKIF4A/miR-152-3p. J Immunol Res. 2022; 2022:2156204. PMC: 9213178. DOI: 10.1155/2022/2156204. View

20.

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View